Company Filing History:

8 out of 145

Connaught Laboratories Limited

patents

5 out of 75

Aventis Pasteur Limited

Years Active: 1999-2015

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8946174 - Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer (2015-02-03),

2. 7851213 - Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer (2010-12-14),

3. 7229625 - Retrovirus-like particles made non-infectious by a plurality of mutations (2007-06-12),

4. 7220826 - Expressing gp140 fragment of primary HIV-1 isolate (2007-05-22),

5. 6923970 - Retrovirus-like particles made non-infectious by a plurality of mutations (2005-08-02),

6. 6544752 - Anigenically-marked non-infectious retrovirus-like particles (2003-04-08),

7. 6544527 - Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region (2003-04-08),

8. 6518030 - Antigentically-marked non-infectious retrovirus-like particles (2003-02-11),

9. 6451322 - Retrovirus like particles made non infectious by a plurality of mutations (2002-09-17),

10. 6342228 - Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markers (2002-01-29),

11. 6291157 - Antigenically-marked non-infectious retrovirus-like particles (2001-09-18),

12. 6235523 - Vectors for DNA immunization against cervical cancer (2001-05-22),

13. 6080408 - Human immunodeficiency virus type 1 nucleic acids devoid of long (2000-06-27),

14. 6025125 - Methods for the detection of HIV-specific immune responses employing (2000-02-15),

15. 5955342 - Non-infectious, replication-defective, self-assembling HIV-1 viral (1999-09-21),

Title: The Innovative Journey of Inventor Shi-Xian Cao

Introduction

Shi-Xian Cao, an accomplished inventor based in Stouffville, Canada, has made significant contributions to the field of cancer research. With an impressive portfolio of 18 patents, her innovative work focuses on developing effective strategies for the prevention and treatment of cancer through targeted immunotherapies.

Latest Patents

Among her latest patents are the tumor antigens BFA4 and BCY1, which present new avenues for cancer prevention and treatment. These inventions relate to a nucleic acid encoding a polypeptide and the utilization of this nucleic acid or polypeptide in combating cancer. Notably, these patents involve improved vectors that facilitate the insertion and expression of foreign genes encoding tumor antigens, providing promising options for immunotherapeutic treatment of cancer.

Career Highlights

Throughout her career, Shi-Xian has collaborated with prominent organizations such as Connaught Laboratories Limited and Aventis Pasteur Limited. Her work in these companies highlights her dedication to advancing medical science through innovative research and development.

Collaborations

Shi-Xian has had the pleasure of working alongside notable professionals, including her coworkers Roy Persson and Benjamin Rovinski. Their collaborative efforts have contributed significantly to the progress and success of her research endeavors in the field of cancer treatment.

Conclusion

In conclusion, Shi-Xian Cao exemplifies the spirit of innovation in the medical and scientific community. Her extensive patent portfolio, particularly in cancer research, underscores her commitment to developing effective therapies that can transform patient outcomes. As she continues her work, the impact of her inventions is anticipated to grow, benefiting countless individuals facing cancer.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.